Hot Stock
Microsofts, Googles und Amazons nukleares Wettrennen macht diese Uranaktie zu einem Muss!
Anzeige
CAREDX INC. DL-,001 WKN: A118WG ISIN: US14167L1035 Kürzel: CDNA Forum: Aktien Thema: Hauptdiskussion
22,37 EUR
+0,77 %+0,17
23. Nov, 12:58:04 Uhr,
Lang & Schwarz
Kommentare 95
Summer.76,
24.02.2021 22:22 Uhr
0
CareDx Reports Fourth Quarter and Full Year 2020 Results
https://finance.yahoo.com/news/caredx-reports-fourth-quarter-full-210100080.html
Recent Highlights:
• Achieved total revenue of $58.6 million for the three months ended December 31, 2020, increasing 64% over prior year fourth quarter
• Delivered record full year revenue of $192.2 million, an increase of 51% compared with full year 2019 revenue
• Provided over 25,000 patient results in the fourth quarter and approximately 79,000 patient results in 2020
• Generated GAAP net loss of $3.5 million, non-GAAP net income of $4.3 million, and positive adjusted EBITDA of $4.9 million in the fourth quarter
• As of December 31, 2020, over 55 U.S.-based transplant centers have adopted an AlloSure Kidney testing protocol
• Received Medicare reimbursement pricing for AlloSure Heart
....
Summer.76,
11.02.2021 5:04 Uhr
0
BRIEF-Ark Investment Management Llc Reports A Passive Stake Of 10.54% In CareDx Inc As Of Jan. 31, 2021
https://pub.webull.com/us/news-html/12ba70cf914647c5afe835a27cedb190.html?theme=2&_v=1&color=1&hl=en&sp=1&_v=1&theme=2&color=1&hl=en
Caredx jumps 10% after Cathie Wood’s ARK takes 10.5% stake
https://seekingalpha.com/news/3660957-caredx-stock-rises-10-on-ownership-disclosure
• ARK Investment Management discloses 5.19M share ownership in CareDX (NASDAQ:CDNA), representing 10.54%.
• The shares contain voting power.
Summer.76,
21.01.2021 6:56 Uhr
0
CareDx Announces Pricing of Public Offering of Common Stock
https://finance.yahoo.com/news/caredx-announces-pricing-public-offering-035600029.html
today announced the pricing of an underwritten public offering of 1,923,077 shares of its common stock at a public offering price of $91.00 per share. The gross proceeds to CareDx from this offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be $175,000,007. In addition, CareDx has granted the underwriters a 30 day option to purchase up to 288,461 additional shares of its common stock offered in the public offering on the same terms and conditions. The offering is expected to close on or about January 25, 2021, subject to the satisfaction of customary closing conditions. ...
Summer.76,
19.01.2021 22:44 Uhr
0
CareDx Announces Proposed Public Offering of Common Stock
https://finance.yahoo.com/news/caredx-announces-proposed-public-offering-211400257.html
...today announced that it intends to offer and sell, subject to market and other conditions, up to $175.0 million of shares of its common stock in an underwritten public offering. CareDx also expects to grant the underwriters of the offering a 30 day option to purchase up to an additional $26.25 million of shares of its of common stock offered in the public offering on the same terms and conditions. All of the shares will be offered and sold by CareDx.
...
Summer.76,
19.01.2021 12:40 Uhr
0
👍
T
Tommy87,
19.01.2021 11:49 Uhr
0
Im organ Bereich gibt es noch transmedics. Auch ein absoluter game changer. Das wird die Organspenden Revolutionieren!
Summer.76,
11.01.2021 15:30 Uhr
0
CareDx Reports Preliminary Fourth Quarter and Full Year 2020 Results
https://www.globenewswire.com/news-release/2021/01/11/2156127/0/en/CareDx-Reports-Preliminary-Fourth-Quarter-and-Full-Year-2020-Results.html
Summer.76,
08.01.2021 15:34 Uhr
0
CareDx Agrees to Acquire TransChart and Expands EMR Connectivity to Over 90 Centers
http://www.globenewswire.com/news-release/2021/01/08/2155496/0/en/CareDx-Agrees-to-Acquire-TransChart-and-Expands-EMR-Connectivity-to-Over-90-Centers.html
Acquisition will build on CareDx’s digital capabilities and continue deepening the moat with transplant centers
...
Summer.76,
07.01.2021 15:08 Uhr
0
CareDx Announces AlloID and Exclusive Partnership with IDbyDNA
https://www.globenewswire.com/news-release/2021/01/07/2154794/0/en/CareDx-Announces-AlloID-and-Exclusive-Partnership-with-IDbyDNA.html
AlloID is a Transplant Patient-Specific Metagenomic Infectious Disease Test Platform, Furthering CareDx’s Innovation in Multi-Modality Surveillance Care
...
Summer.76,
04.01.2021 15:25 Uhr
0
CareDx’s AlloSeq HCT Wins Tender for French Stem Cell Transplant Patient Surveillance
https://www.globenewswire.com/news-release/2021/01/04/2152520/0/en/CareDx-s-AlloSeq-HCT-Wins-Tender-for-French-Stem-Cell-Transplant-Patient-Surveillance.html
CareDx wins a 2-year competitive tender with the French National Blood Service, Établissement Français du Sang
...
Summer.76,
03.01.2021 14:48 Uhr
0
CareDx: Stock To Achieve Significant Long-Term Growth
https://seekingalpha.com/article/4397022-caredx-stock-to-achieve-significant-long-term-growth
Summary
CareDx offers organ testing products that are non-invasive alternatives to more invasive traditional tests.
The organ transplant market is expected to grow through 2027, creating a tailwind for CareDx.
While the company's growth is strong and above-average, the valuation and near overbought level needs to be considered.
...
Summer.76,
22.12.2020 16:31 Uhr
0
CareDx Celebrates the Long-Awaited Passage of the Immuno Bill
http://www.globenewswire.com/news-release/2020/12/22/2149535/0/en/CareDx-Celebrates-the-Long-Awaited-Passage-of-the-Immuno-Bill.html
Partners with large transplant coalition to expand access to lifesaving medications for kidney transplant patients
...
Summer.76,
10.12.2020 16:00 Uhr
0
CareDx price target raised to $75 from $62 at Raymond James
https://thefly.com/landingPageNews.php?id=3210563&headline=CDNA-CareDx-price-target-raised-to--from--at-Raymond-James
Meistdiskutiert
|
Thema | ||
---|---|---|---|
1 | VW Hauptdiskussion | -0,05 % | |
2 | MicroStrategy | +1,69 % | |
3 | BTC/USD Hauptdiskussion | -0,53 % | |
4 | CFC INDUSTRIE Hauptdiskussion | -3,70 % | |
5 | Goldpreis Hauptdiskussion | ±0,00 % | |
6 | BIOXCEL THERAPEUT DL-,001 Hauptdiskussion | +4,08 % | |
7 | MICROSTRATEGY Hauptdiskussion | +1,69 % | |
8 | POWERHOUSE ENERGY GROUP Hauptdiskussion | ±0,00 % | |
9 | Rund ums Thema , allgemeine Artikel für Leseratten. | ±0,00 % | |
10 | Trading- und Aktien-Chat | Alle Diskussionen |
Aktien
|
Thema | ||
---|---|---|---|
1 | VW Hauptdiskussion | -0,05 % | |
2 | MicroStrategy | +1,69 % | |
3 | CFC INDUSTRIE Hauptdiskussion | -3,70 % | |
4 | BIOXCEL THERAPEUT DL-,001 Hauptdiskussion | +4,08 % | |
5 | POWERHOUSE ENERGY GROUP Hauptdiskussion | ±0,00 % | |
6 | Rund ums Thema , allgemeine Artikel für Leseratten. | ±0,00 % | |
7 | MICROSTRATEGY Hauptdiskussion | +1,69 % | |
8 | VUZIX Hauptdiskussion | -2,38 % | |
9 | ROCK TECH LITHIUM Hauptdiskussion | ±0,00 % | |
10 | THYSSENKRUPP Hauptdiskussion | ±0,00 % | Alle Diskussionen |